English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  With the increasing utilization of  68 Ge- 68 Ga radionuclide generators,  68 Ga labelled peptides like DOTATATE are receiving more attention in nuclear medicine. On the one hand, the long half-life of the parent nuclide  68 Ge is an enormous advantage for routine applications, but the question of the long-term stability of the  68 Ge breakthrough arises, which up to now has scarcely been investigated.    Method  A sum of 123 eluates from four different  68 Ge- 68 Ga generators (iThemba Labs, Faure, South Africa) and 115 samples of the prepared radiopharmaceutical  68 Ga-DOTATATE were measured first with a dose calibrator and again after decay of the eluted  68 Ga via gamma-ray spectrometry. A complete decay curve was recorded for one sample eluate. A further three eluates were eluted in ten fractions of 0.5 ml in order to obtain detailed information concerning the distribution of the two nuclides within the eluates. The influences of factors such as the amount of DOTATATE, addition of Fe 3+  salts and replacement of HEPES buffer with sodium acetate on the radiochemical synthesis were also tested.    Results  The content of long-lived  68 Ge breakthrough increases over the entire period of use to more than 100 ppm. The labelling process with the chelator DOTA removes  68 Ge efficiently. The maximum activity found in the residues of the radiopharmaceuticals investigated in this study was below 10 Bq in nearly all cases. In many cases (12% of the labelled substance), the long-lived parent nuclide could not be identified at all. The labelling process is still viable for reduced amounts of the chelator and with acetate buffer.    Conclusion  Effective doses received by the patient from  68 Ge in the injected radiopharmaceutical  68 Ga-DOTATATE are lower than 0.1 μSv and are therefore practically negligible, especially when compared with the contribution of the PET radiopharmaceutical itself. Gamma-ray spectrometry as recommended by the European Pharmacopeia is suitable for quantification of radionuclidic impurities.    Electronic supplementary material  The online version of this article (doi:10.1186/s13550-014-0036-4) contains supplementary material, which is available to authorized users.

Characterization of SnO2-based 68Ge/68Ga generators and 68Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy